Investment Test Drive

ZBIO ProShares UltraPro Short Nasdaq Biotech

1 lower fee alternative found

FeeX scanned the market for similar funds with lower fees and better past returns
Show results with
Investing
$
  YOU ASKED ABOUT FEATURED ALTERNATIVE ?
Fund ZBIO ProShares UltraPro Short Nasdaq Biotech PILS Direxion Daily Pharmctcl&Medcl Br 2X ETF  
Similarity
?
100% 86%
Annual Fees
?
$85.75
(0.95% Exp. Ratio)
$73.12
(0.81% Exp. Ratio)
Future Est. Balance in 30 yrs
Assuming -9.73% annual return
$348.10 $363.17
Est. savings over 30 yrs +$15.07
Return
As of 11/30/16
1 YR RETURN 0.18%
3 YR --
5 YR --
10 YR --
1 YR RETURN 28.07%
3 YR --
5 YR --
10 YR --
Description
The investment seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the NASDAQ Biotechnology Index®. The fund invests in derivatives that the advisor believes, should have similar daily return characteristics as three times the inverse of the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.
The investment seeks daily investment results of 200% of the inverse of the performance of the Dynamic Pharmaceutical Intellidex Index. The fund, under normal circumstances, creates short positions by investing at least 80% of its assets in: swap agreements; futures contracts; options; reverse repurchase agreements; exchange-traded funds ("ETFs"); and other financial instruments that, in combination, provide inverse leveraged and unleveraged exposure to the Dynamic Pharmaceutical Intellidex Index. The index consists of common shares of U.S. pharmaceutical companies. It is non-diversified.

Join FeeX to view all alternatives, get more data and filtering options, and be able to automatically scan all your investments for lower fee replacements.

It's free!

The fees, balance and savings information above are estimated numbers, based on the data FeeX had at the day of publication, but may not be accurate due to incomplete or erroneous data.

The best choice is based on a combined analysis of lowest fees and highest similarity to the original fund.

Similarity

FeeX's similarity algorithm analyzes over 15 investment characteristics like investment category, asset allocation, strategy, geographical allocation and more. FeeX gives each its own weight and calculates the similarity of any two investments based on a scale of 0 to 100%. Funds with a similarity ranking of 85% and higher are considered "similar".

Yes, funds and ETFs charge fees

Deep within every fund you own lies a hidden fee called expense ratio. It takes away a set % of your savings each and every year. It can often be easily reduced by switching to similar investments with lower expense ratios.

+

Your Feedback has been sent successfully!